Boostrix

Boostrix Description

Manufacturer:

GlaxoSmithKline Indonesia
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Description
1 dose (0.5 mL) contains: Diphtheria toxoid1 not less than 2 International units (IU) (2.5 Lf); Tetanus toxoid1 not less than 20 International units (IU) (5 Lf); Bordetella pertussis antigens: Pertussis toxoid1 8 micrograms, Filamentous haemagglutinin1 8 micrograms, Pertactin1 2.5 micrograms.
1adsorbed on aluminium hydroxide (Al(OH)3) 0.3 milligrams Al3+ and aluminium phosphate (AlPO4) 0.2 milligrams Al3+.
Upon storage, a white deposit and clear supernatant can be observed. This is a normal finding.
Excipients/Inactive Ingredients: Sodium chloride, water for injections.
Formaldehyde, polysorbate 80, glycine are present as residuals from the manufacturing process.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in